Insider Transactions in Q1 2022 at Quanterix Corp (QTRX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 23
2022
|
David C. Duffy SVP R&D and CTO |
SELL
Open market or private sale
|
Direct |
3,266
-5.63%
|
$97,980
$30.0 P/Share
|
|
Mar 01
2022
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
267
-0.36%
|
$8,277
$31.68 P/Share
|
|
Mar 01
2022
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
371
-0.6%
|
$11,501
$31.68 P/Share
|
|
Mar 01
2022
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
589
-0.03%
|
$18,259
$31.68 P/Share
|
|
Mar 01
2022
|
Mark T. Roskey SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct |
166
-0.37%
|
$5,146
$31.68 P/Share
|
|
Feb 09
2022
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
1,364
-0.15%
|
$46,376
$34.97 P/Share
|
|
Feb 09
2022
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
318
-0.84%
|
$10,812
$34.97 P/Share
|
|
Feb 09
2022
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
481
-1.52%
|
$16,354
$34.97 P/Share
|
|
Feb 09
2022
|
Mark T. Roskey SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct |
292
-1.27%
|
$9,928
$34.97 P/Share
|
|
Feb 04
2022
|
David C. Duffy SVP R&D and CTO |
SELL
Open market or private sale
|
Direct |
3,266
-5.33%
|
$97,980
$30.91 P/Share
|
|
Feb 02
2022
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
371
-0.58%
|
$11,501
$31.68 P/Share
|
|
Feb 02
2022
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
589
-0.03%
|
$18,259
$31.68 P/Share
|
|
Feb 02
2022
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
267
-0.35%
|
$8,277
$31.68 P/Share
|
|
Feb 02
2022
|
Mark T. Roskey SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct |
166
-0.36%
|
$5,146
$31.68 P/Share
|
|
Jan 31
2022
|
David C. Duffy SVP R&D and CTO |
SELL
Open market or private sale
|
Direct |
3,266
-5.06%
|
$97,980
$30.0 P/Share
|
|
Jan 03
2022
|
David C. Duffy SVP R&D and CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
41,246
+21.74%
|
$82,492
$2.71 P/Share
|
|
Jan 03
2022
|
David R Walt |
BUY
Grant, award, or other acquisition
|
Direct |
2,668
+0.21%
|
-
|
|
Jan 03
2022
|
Laurie J Olson |
BUY
Grant, award, or other acquisition
|
Direct |
2,668
+27.02%
|
-
|
|
Jan 03
2022
|
Paul M Meister |
BUY
Grant, award, or other acquisition
|
Direct |
2,992
+7.86%
|
$62,832
$21.21 P/Share
|
|
Jan 03
2022
|
Sarah E. Hlavinka |
BUY
Grant, award, or other acquisition
|
Direct |
2,948
+8.67%
|
$61,908
$21.21 P/Share
|
|
Jan 03
2022
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
355
-0.93%
|
$14,555
$41.91 P/Share
|
|
Jan 03
2022
|
Mark T. Roskey SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct |
149
-0.64%
|
$6,109
$41.91 P/Share
|
|
Jan 03
2022
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
3,715
-0.42%
|
$152,315
$41.91 P/Share
|
|
Jan 03
2022
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
352
-1.09%
|
$14,432
$41.91 P/Share
|
|
Jan 03
2022
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct |
3,095
+7.58%
|
$64,995
$21.21 P/Share
|
|
Jan 03
2022
|
Keith Crandell |
BUY
Grant, award, or other acquisition
|
Direct |
2,975
+1.24%
|
$62,475
$21.21 P/Share
|